Human ADME Studies

How can I simplify the delivery of my Human ADME Study?
Contact us
Human ADME studies at Quotient Sciences
Assessing the Impact of the Approved FDA Guidance on Human Mass Balance Studies: How ADME programs will proceed in 2024 and beyond
Read More
Ask The Experts

Human ADME study questions? Get answers from our team.

Have a question about your next human ADME program or other clinical pharmacology programs that we offer? Ask a member of our team about our capabilities.

 

Dr. Andrew Lewis

Chief Scientific Officer

Dr. Andrew (Andy) Lewis is the Chief Scientific Officer at Quotient Sciences. As the leader of Quotient Sciences' scientific teams...

About Andrew
Iain Shaw

Senior Director, 14C Enabled Drug Development

Iain Shaw has over 30 years of experience in the pharmaceutical industry, including over 15 years focused on 14C-enabled drug deve...

About Iain
Dr. Adam Robinson-Miller

Senior Manager, 14C Enabled Drug Development

Dr. Adam Robinson-Miller has more than a decade of experience in the pharmaceutical and OTC environments, with particular focus on...

About Adam
Meet More of Our Experts

More about our human ADME capabilities

Browse More
Info Sheets, Human ADME, Clinical Pharmacology
Human ADME Capabilities Info Sheet
9 June 2025
Download Now
Whitepapers, Human ADME
Synthesis-to-Clinic®: A streamlined approach to 14C human ADME studies
Download Now
Articles & Publications, Human ADME
ADME of opicapone in human healthy volunteers
16 June 2022
Download Now
Articles & Publications, Human ADME, Clinical Pharmacology, First-in-Human
Astrazeneca - Characterization of Clinical ADME & Pharmacokinetics of Velsecorat Using an IV Microtracer Combined with an Inhaled Dose in Healthy Subjects
2 February 2022
Download Now
Browse More
Your Next Program
Every day counts for patients. Let's move your therapy forward together.
Let's Talk Ask The Experts